Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Galapagos NV (GXEA.F)

Compare
25.60
+0.40
+(1.59%)
As of 8:09:25 AM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
260,094
239,724
241,249
234,384
478,053
Cost of Revenue
--
--
12,079
1,629
--
Gross Profit
--
--
493,201
483,217
478,053
Operating Expense
412,933
327,987
372,306
405,949
656,685
Operating Income
-171,963
-88,263
-131,057
-171,565
-178,632
Net Non Operating Interest Income Expense
95,335
77,636
8,709
-9,296
-14,867
Other Income Expense
11,763
16,252
51,499
61,462
-116,276
Pretax Income
-64,866
5,625
-70,849
-119,402
-309,775
Tax Provision
-4,255
9,613
572
1,389
1,226
Net Income Common Stockholders
206,334
211,697
-217,991
-103,231
-305,436
Diluted NI Available to Com Stockholders
206,334
211,697
-217,991
-103,231
-305,436
Basic EPS
3.13
3.21
-3.32
-1.58
-4.69
Diluted EPS
3.13
3.21
-3.32
-1.58
-4.69
Basic Average Shares
65,801.66
65,884
65,659.94
65,500
65,075
Diluted Average Shares
65,801.66
65,884
65,659.94
65,500
65,075
Total Operating Income as Reported
-171,964
-88,263
-131,056
-171,568
-178,632
Total Expenses
432,057
327,987
372,306
405,949
656,685
Net Income from Continuing & Discontinued Operation
206,334
211,697
-217,991
-103,231
-305,436
Normalized Income
-71,602.39
-16,177
-110,045.25
-166,887.50
-228,445.04
Interest Income
97,065
79,608
18,094
2,865
10,030
Interest Expense
1,528
1,770
9,155
11,592
9,389
Net Interest Income
95,335
77,636
8,709
-9,296
-14,867
EBIT
-63,338
7,395
-61,694
-107,810
-300,386
EBITDA
-63,338
51,037
3,872
-73,174
-281,704
Reconciled Cost of Revenue
--
--
12,079
1,629
--
Reconciled Depreciation
--
43,642
65,566
34,636
18,682
Net Income from Continuing Operation Net Minority Interest
-60,611
-3,988
-71,421
-120,791
-311,001
Total Unusual Items Excluding Goodwill
11,763
16,252
51,499
61,462
-116,276
Total Unusual Items
11,763
16,252
51,499
61,462
-116,276
Normalized EBITDA
-75,101
34,785
-47,627
-134,636
-165,428
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
771.61
4,063
12,874.75
15,365.50
-33,720.04
12/31/2020 - 5/20/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

9PT.F Pliant Therapeutics Inc
2.8600
+0.70%
 
50BA.SG Bicycle Therapeutics PLC
10.80
-1.82%
 
AURA Aura Biosciences, Inc.
7.44
-0.93%
 
TRVI Trevi Therapeutics, Inc.
4.3950
-4.46%
 
NCNA NuCana plc
1.0297
-5.53%
 
CNTA Centessa Pharmaceuticals plc
15.90
-4.39%
 
ADAP Adaptimmune Therapeutics plc
0.5508
-1.55%
 
VIR Vir Biotechnology, Inc.
9.47
-1.04%
 
ALNY Alnylam Pharmaceuticals, Inc.
249.02
-0.63%
 
CADL Candel Therapeutics, Inc.
11.12
-4.39%